Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
JHL Biotech's Final Trading Day on Taipei Exchange 2018-02-12 08:00
JHL Biotech's Application to Voluntarily Terminate Trading of Shares Approved by Taipei Exchange 2018-02-05 08:53
JHL Biotech Shareholders Vote to Voluntarily Delist from Taiwan Exchange 2018-02-01 22:00
JHL Biotech Welcomes New Chief Medical Officer, Rong Chen 2018-01-02 06:55
JHL Biotech Submits Clinical Trial Application in Europe for Proposed Dornase Alfa Biosimilar to Affordably Manage Symptoms of Cystic Fibrosis 2017-12-21 02:42
JHL Biotech Submits Clinical Trial Application in Europe for Proposed Bevacizumab Biosimilar to Treat Colorectal, Lung, and Ovarian Cancers 2017-12-20 23:46
JHL Biotech and Affinita Biotech Agree to Partner in the Development and Manufacturing of Oncology Monoclonal Antibodies 2016-03-01 07:45
JHL Biotech Receives Approval From European Authorities to Begin Biosimilar Clinical Trial 2016-02-15 08:00
JHL Biotech Appoints New Leaders to Management Team 2015-10-20 16:00
JHL Biotech Lists on the Taiwan Emerging Stock Board 2015-10-03 01:33
1